We use first and third-party cookies to offer our services and collect statistical data. If you continue browsing this website you accept their use.
More information
Accept
HOME
SERVICES
FDF SOLUTIONS
B2B EXPORT
PRODUCTS
CNS PHARMACEUTICALS
CNS NUTRACEUTICALS
OTHER PHARMACEUTICALS
PRODUCT PORTFOLIO
FULL RANGE OF NEURAXPHARM PRODUCT LIST
EXPERTISE
ORAL SOLID FOCUS
INNOVATION
QUALITY CERTIFICATES
ABOUT US
LESVI
OUR HISTORY
NEURAXPHARM GROUP
NON-FINANCIAL REPORT
JOIN US
CONTACT US
LINKEDIN
NEURAXPHARM GROUP
See Neuraxpharm’s sites
Austria
Czechia
Denmark
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Poland
Portugal
Norway
Slovakia
Spain
Sweden
United Kingdom
Manufacturing plants
FDFs | LESVI
APIs | INKE
Neuraxpharm Group
CORPORATE WEBSITE
EXPERTISE /
QUALITY CERTIFICATES
QUALITY
Lesvi has been successfully inspected by every major global health authority
New machinery and facilities approval AEMPs (last inspection 2019)
Local Authorities Renewal of GMP compliance – Generalitat (last inspection 2019)
Belarus Health Authorities (2017)
Lesvi has international authorisation for the following pharmaceutical forms:
TABLETS · CAPSULES · POWDERS · STERILES AND NON-STERILES
MORE
OUR
RESULTS
Successful internal/external audits
High regulatory performance
More than 125 granted patents in the most important countries worldwide
More than 220 dossiers (FDF) submitted to Regulatory agencies of different territories